CVKD financials

Cadrenal Therapeutics (CVKD) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

CVKD income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$13.46M-$13.24M-6.64
2024––-$10.96M-$10.65M-8.73
2023––-$7.63M-$8.36M-9.29
2022––-$2.70M-$6.71M-12.75